Glioma is a type of tumor that occurs in the brain and/or spinal cord that begins in the glial cells that surround nerve cells.
Glioma can affect your brain function and be life-threatening depending on their location and rate of growth. Approximately 18,500 people in the U.S. are diagnosed with a glioma each year.
Researchers have discovered through genetic testing of the tumor, they can accurately identify the sub-type of glioma. This testing:
Tests look for three specific mutations in the patient's DNA.
Depending on the combination of mutations, doctors can place a patient in one of 5 groups.
Choose the treatment that offers the best possible prognosis for each patient.
How it benefits the patient.
Source: "Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors," New England Journal of Medicine (June 2015), Mayo Clinic and the University of California, San Francisco; CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
允许将材料复制单份副本，但仅限于非商业用途之个人使用。 "Mayo"（妙佑医疗）、"Mayo Clinic"（妙佑医疗国际）、"MayoClinic.org"、"Mayo Clinic Healthy Living"（妙佑医疗国际健康生活）以及妙佑医疗国际三盾徽标均为 Mayo Foundation for Medical Education and Research（妙佑医学教育和研究基金会）商标。